Morning Brief — Friday, September 11, 2026

Market Overview

Equity futures are pushing higher Friday morning (+0.8% on SPY) as traders digest fresh CPI data following a brutal four-day market slide. The macro backdrop is supportive at the margins — oil prices are pulling back, which relieves some inflationary pressure — but the real story today is company-specific: a major M&A deal in used-car auctions (ACVA/CPRT), a semiconductor merger closing in on approval (SWKS/QRVO), and AI infrastructure names like DELL and HPE catching analyst upgrades. The CPI print will set the tone for rate expectations heading into the Fed’s next meeting, making this a pivotal session for how growth stocks trade into the weekend.

Claude’s Call

UP — The four-day selloff was overdone relative to fundamentals, and today’s CPI release appears to be coming in constructively enough to trigger a relief rally; with deal flow active, analyst upgrades hitting AI hardware, and futures already bid, the path of least resistance is higher — but don’t mistake a dead-cat bounce for a trend reversal.

Top Movers

ACVA (+44.5%) — $10.44 → $12.14 (+16.3% upside) Thesis: Copart (CPRT) agreed to acquire ACV Auctions in an all-cash deal valued at ~$1.9 billion — this is the cleanest catalyst you’ll see all year. ACVA is trading at deal price, meaning there’s minimal spread left unless the deal bumps or closes faster than expected. At $10.44, ACVA is trading right at its 6-month high and the 20-day high simultaneously — there is no overhead resistance because the stock has been repriced by the acquisition. The fib extension target of $12.14 (1.272x) represents a scenario where the market prices in a deal bump or competing bid, but I wouldn’t bet on it. This is a deal lock situation — you’re collecting the arb spread, not playing momentum. Levels: Exit at $12.14 (fib 1.272 extension / potential bump target). Support at $8.95 (fib 23.6% retracement) — but below deal price means deal risk is being priced in, treat that as a stop.

SWKS (+9.8%) — $84.03 → $95.54 (+13.7% upside) Thesis: The CEO announced at the Goldman Sachs conference that the $22B merger with Qorvo is in its “final stages” — that’s as close to a greenlight as you get without an official filing. SWKS is trading at its 6-month high ($86.24 in technicals vs. $84.03 reported price), breaking out of a multi-month base that started at $52. The 50-day SMA is all the way down at $65.93, meaning this stock has already repriced significantly — but the merger catalyst is real and the closing timeline is tightening. If the deal gets official regulatory sign-off, SWKS has a clear path to the fib 1.272 extension at $95.54. Levels: Exit at $95.54 (fib 1.272 extension). Support at $78.17 (fib 23.6%) — a violation here would suggest deal concern is creeping in.

QRVO (+6.8%) — $112.36 → $125.20 (+11.4% upside) Thesis: Same merger catalyst as SWKS — the Skyworks deal closing in on approval is lifting the target as well. QRVO is the acquisition target here, so it has slightly more binary risk: deal closes = stock likely moves higher toward terms; deal breaks = stock falls hard back to pre-announcement levels (~$76). At $112.36, you’re trading at about a 3-4% discount to where you’d expect an all-cash deal to price, which is a reasonable arb. Note that QRVO and SWKS are moving in near-lockstep — this is a merger spread play, not independent stock-picking. Levels: Exit at $125.20 (fib 1.272 extension / deal close repricing). Support at $105.56 (fib 23.6%); a break below $99.91 (fib 38.2%) signals deal concern.

DELL (+5.8%) — $535.98 → $643.96 (+20.1% upside) Thesis: DELL entered the S&P 100 after a ~700% three-year rally and today is seeing a double catalyst: Evercore ISI raised its price target to $650 citing a $95 billion AI server backlog, and RBC sees 26% upside. The stock is at its 6-month high ($537.62 in technicals), which means it’s in price discovery territory. This is a genuine AI infrastructure story — not sympathy trade — with backlog math that supports the multiple. The 50-day SMA at $448 is far below, so short-term pullbacks could be sharp. Insider selling is a yellow flag per the news flow, but institutional buy-side upgrades are overwhelmingly positive today. Levels: Exit at $643.96 (fib 1.272 extension, aligns with Evercore target). Support at $445.36 (fib 23.6%) — a long way down, so size accordingly.

ELV (+5.4%) — $416.54 → $463.71 (+11.3% upside) Thesis: Elevance Health is trading near its 6-month high ($424.94) after a 40%+ six-month run, driven by managed care sector rotation and a Deutsche Bank sector read. Today’s move likely reflects the ex-dividend date having passed (Sept 10), repositioning into the name, and broader managed care strength following UNH/Optum news flow. The structural story here is margin recovery — ELV lost significant margin in recent quarters and the market is pricing in a snapback. This is a defensive sector play in a rising-VIX environment, and the technicals support it with the stock holding above the 50-day SMA ($395.67) and breaking toward the 6-month high. Levels: Exit at $463.71 (fib 1.272 extension). Support at $391.30 (fib 23.6%, just above the 50-day SMA).

ASO (+6.0%) — $54.22 → $63.34 (+16.8% upside) Thesis: Academy Sports delivered a genuine earnings beat — EPS came in at $5.96 with gross margins up 440 basis points YoY, boosted partly by tariff refunds. The company raised its full-year EPS outlook even as comparable sales dipped slightly — that’s a quality beat on the bottom line. The stock surged 14% on Wednesday and is continuing to build on that move. At $54.22, it’s just above the fib 23.6% support at $55.07 (inverted — this is a breakout stock now testing that former resistance as support). The bifurcated consumer theme (lower-income pressure, higher-margin product mix shift) is real but manageable. Analyst target sits at $59.85, leaving ~10% to consensus. Levels: Exit at $63.34 (fib 1.272 extension). Support at $50.77 (fib 50%) — below that, the earnings gap partially fills.

HPE (+5.2%) — $58.08 → $70.32 (+21.1% upside) Thesis: HPE is getting fresh legs from the AI infrastructure buildout narrative — multiple analyst pieces today calling it a “high-momentum AI hardware” play alongside DELL. The stock has rallied 26% in three months and is approaching its 6-month high of $59.82. Unlike DELL, HPE hasn’t had the parabolic move yet — it’s still trading at a significant discount to where its AI server backlog would imply fair value. The fib 1.272 extension at $70.32 is the natural target if the AI capex cycle sustains. EV/EBITDA comps aren’t available but the stock trades cheaply on most hardware metrics. Levels: Exit at $70.32 (fib 1.272 extension). Support at $50.71 (fib 23.6%) and the 50-day SMA at $51.03.

AEHR (+5.0%) — $98.50 → $118.35 (+20.2% upside) Thesis: Oppenheimer published a bullish note calling Aehr “poised for an AI-driven inflection” — the thesis being that as AI processor values rise, the cost of late-stage failures rises too, making Aehr’s wafer-level burn-in testing equipment more mission-critical. Hedge fund holdings have jumped 8x per recent filings. That said, AEHR has pulled back hard from its 6-month high of $145.61 and is currently sitting near the fib 38.2% support ($101.49) — this is a bounce-off-support setup, not a breakout. The 50-day SMA at $91 provides secondary support. Oppenheimer initiation is a real catalyst but this stock is volatile and has already fallen 30%+ from peak. Levels: Exit at $118.35 (fib 23.6% retracement, first meaningful overhead resistance). Support at $91.04 (50-day SMA) — a close below that is a stop signal.

Headlines to Watch

Copart to Acquire ACV Auctions for $1.9 Billion in All-Cash Deal — Sets a precedent for auto-adjacent fintech/marketplace valuations; watch CPRT for any deal-related dilution risk and monitor for competing bids that could push ACVA toward the $12 fib extension.
Skyworks CEO Says $22B Qorvo Merger in Final Stages — If official regulatory clearance drops today or over the weekend, SWKS could gap toward $95 and QRVO toward the high $110s; this is the most time-sensitive catalyst in the mover list right now.
Evercore ISI Sets $650 Target on Dell, Cites $95B AI Server Backlog — The backlog figure is the key metric to track for DELL; if next earnings show backlog growth slowing, the $650 target evaporates quickly — for now it’s a tailwind.
CPI Data Released Pre-Market Friday — Futures are up 0.8% suggesting the print came in constructively; a soft CPI keeps the “higher-for-longer” narrative at bay and is specifically positive for growth names (NVDA, ORCL) that have been under pressure all week.
Deutsche Bank Initiates Clover Health (CLOV) at Buy, $6 PT — A new Buy initiation on a healthcare name that turned profitable in Q2 with 48% Medicare Advantage membership growth; the $6 target implies ~27% upside from current levels and gives the meme-stock-adjacent CLOV some fundamental cover.
Dell Enters S&P 100 After 700% Three-Year Rally — Index inclusion drives passive buying flows and signals the Street’s acceptance of DELL as a mega-cap AI infrastructure name; watch for any index-rebalancing selling to create dip opportunities.
NuScale Power (SMR) Cut to Sell by UBS on Timeline and Cash Burn — A warning shot for speculative nuclear/SMR plays trading on hype timelines; if you’re long SMR, RNW, or OKLO, today’s action is a reminder that execution risk is very real in pre-revenue energy tech.

Claude’s Top Picks

DELL (+5.8% today, +3.8% week) — $535.98 → $643.96 (+20.1% upside) Valuation: No comps provided, but at ~$537 with a $95B AI server backlog, the stock is pricing in sustained hyper-scaler demand — which is justified given Evercore’s $650 target and S&P 100 inclusion momentum. Upside: The AI infrastructure buildout isn’t slowing, backlog figures are accelerating, and index inclusion adds passive buying pressure on top of fundamental upgrades. Risk: Insider selling noted in recent filings is a yellow flag; if Q3 backlog growth disappoints or AI capex spending by hyperscalers slows, the multiple compresses fast from elevated levels.

ELV (+5.4% today, +3.1% week) — $416.54 → $463.71 (+11.3% upside) Valuation: ELV is trading near a 6-month high but still below its historical peak; in the managed care peer group (UNH, CI, CVS), ELV screens as the most compelling margin recovery story at a reasonable multiple. Upside: Managed care is acting as a defensive rotation into a high-VIX environment, the ex-dividend repositioning is done, and the margin recovery narrative has legs through year-end as medical utilization normalizes. Risk: If Medicare Advantage rate pressures resurface (a recurring theme for the sector) or medical loss ratios come in worse than expected in Q3, the entire sector re-rates lower and ELV gives back this week’s gains.

AEHR (+5.0% today, +29.2% week) — $98.50 → $118.35 (+20.2% upside) Valuation: No formal comps provided, but AEHR is a niche semiconductor test equipment play — it’s priced on order cycle momentum, not earnings multiples, and the Oppenheimer AI thesis is a genuine re-rating catalyst. Upside: The stock is bouncing off fib 38.2% support at $101, hedge fund holdings just spiked 8x, and Oppenheimer’s AI processor testing thesis is differentiated and structural — not just a sympathy trade. Risk: AEHR has already fallen 32% from its 6-month high of $145.61 and has a history of violent swings around order announcements; if the AI processor testing orders don’t materialize on the timeline Oppenheimer expects, this gives back all of today’s gains and then some.

ASO (+6.0% today, +24.4% week) — $54.22 → $63.34 (+16.8% upside) Valuation: Trading at roughly 9x forward earnings after the beat — cheap for a retailer with improving margins and an e-commerce acceleration story; the raised EPS guidance makes this look even more attractive on a forward basis. Upside: 440bp gross margin expansion driven by tariff refunds plus a raised full-year EPS guide is a genuine fundamental re-rate; the stock is just breaking out above 6-month resistance, and analyst targets at $59.85 still have room to move higher after this quarter. Risk: The CEO flagged lower-income consumer pressure directly on the call — comparable sales were slightly negative — and if the macro deteriorates further into the holiday season, comps could turn uglier than the margin beat implies.

HPE (+5.2% today, +6.7% week) — $58.08 → $70.32 (+21.1% upside) Valuation: HPE screens significantly cheaper than pure-play AI names, trading at a fraction of DELL’s multiple — the gap is starting to close as the market recognizes HPE’s AI server exposure, but there’s still meaningful catch-up potential. Upside: HPE is the most underappreciated AI hardware name in the large-cap space; approaching but not yet at its 6-month high ($59.82), meaning there’s technical room to run before it gets extended, unlike DELL which is already in price-discovery territory. Risk: HPE has less differentiation than DELL in the AI server space and a history of weak execution on margin targets; if DELL’s backlog narrative falters, HPE gets hit harder given its thinner moat.

Avoid

ACVA — At $10.44 you’re essentially holding a deal spread, not a trade — the 44% has already been made, and chasing an M&A target after the initial pop for a “bump” thesis is a low-probability, high-risk game that mostly ends in frustration.

WLTH — The RSI at 15.11 (deeply oversold) and volume ratio of just 0.17 (well below average) tell the real story here: today’s 15% move is happening on almost no volume, which is a hallmark of thin, unsustainable pops — the $100B AUM milestone is genuinely positive but the stock needs volume confirmation before this is a buy.

AGL — Agilon Health is trading below its 50-day SMA ($100.40) and well off its 6-month high ($129.84); the stock dropped hard after a quarter that beat on revenue and margins, which is a classic “sell the news” setup suggesting the buy-side was already positioned — an RSI of 3.16 tells you the stock is technically wrecked and needs to base before it’s worth owning again.

WSB Sentiment Check

ORCL — WSB says: BULLISH (80% bullish, 247 mentions, 556 upvotes) Claude says: PARTIALLY AGREE — ORCL is trading at $155.32, a full 37% below its 6-month high of $247.29, and the 50-day SMA at $140.73 is the only thing holding it up right now; WSB is right that the cloud/AI narrative is intact, but the chart is in a confirmed downtrend from $247 and you’re catching a falling knife if you buy the spike today — wait for a close above $165 (fib 61.8%) before getting excited.

USO — WSB says: BULLISH (80% bullish, 123 mentions, 263 upvotes) Claude says: DISAGREE — Oil is dropping today per the market headlines (specifically called out as a reason for equity strength), yet WSB is piling into USO; the technicals show USO sitting below its 6-month high of $158.38 with fib 23.6% support at $145.37 already being tested — this smells like a crowded trade fading in real time, and buying oil into a risk-on relief rally with softer CPI is the wrong rotation call.

AAPL — WSB says: BEARISH (30% bullish, 91 mentions, 492 upvotes) Claude says: PARTIALLY AGREE — AAPL at $331.95 is approaching its 6-month high of $339.79 and the 20-day high simultaneously; the chart isn’t broken, and the 50-day SMA at $317.82 provides solid support — WSB’s bearish lean is probably frustration that the stock hasn’t followed the AI hype higher rather than a fundamental thesis; I’d say neutral-to-cautiously bullish with a stop at the 50-day.

NVDA — WSB says: MIXED (55% bullish, 75 mentions, 395 upvotes) Claude says: AGREE (MIXED IS RIGHT) — NVDA at $219.76 is sitting right on its fib 23.6% support at $218.59, which is a technically important inflection point; the stock is off its 6-month high of $235.20 and has struggled to regain momentum — the AI capex story is real but insider disposals and bearish options positioning (per general market news) suggest smart money is hedging; this is a hold, not a conviction buy or sell today.

MU — WSB says: BEARISH (30% bullish, 70 mentions, 125 upvotes) Claude says: AGREE — MU at $985.74 has fallen from a 6-month high of $1,213.37 and the fib 23.6% support at $1,002.95 has already been broken to the downside; the 50-day SMA at $928.82 is the next meaningful support, implying another ~6% of downside risk from here — memory cycle concerns are real, the chart is broken, and WSB’s bearish read is technically supported for once.

Earnings Scorecard

ASO — BEAT | Stock: +6.0% today (+14% Wednesday) | Reported: Wednesday After Close EPS $5.96 with gross margins up 440bps and a raised full-year guide — the reaction is fully justified and arguably still under-done given the magnitude of the margin beat; this is a buy-the-dip if it pulls back to $50-51 support.

CHWY — REPORTED (EPS $0.65) | Stock: -3.3% Revenue beat on customer growth but the market sold it anyway — classic “sell the news” on a stock that had already run into earnings; with analyst target at $29.05 the dip is worth watching but the -3.3% reaction suggests guidance was uninspiring; hold, not a chase.

KR — REPORTED (EPS $1.71) | Stock: +1.5% Kroger cut sales guidance which is the headline risk, yet the stock is up 1.5% — the market is shrugging off guidance cuts because EPS held firm; with analyst target at $69.77 and the stock likely in the mid-$60s, there’s modest upside but no urgency to buy.

AVAV — REPORTED (EPS -$4.06) | Stock: -2.1% Despite beating on revenue (described as “record revenue crushes estimates”), the stock is down 2.1% — this is a classic defense contractor pattern where the headline EPS is distorted by non-cash items; analyst target at $226.50 implies significant upside, and the -2.1% reaction appears overdone — watch for a buy-the-dip setup in the $220s.

SAIL — REPORTED (EPS -$0.34) | Stock: -1.7% SaaS ARR up 36% YoY is genuinely strong and the AI pipeline narrative is intact, yet the stock slipped 1.7% — at analyst target of $20.84 with current price likely in the $19-20 range, the market appears to be digesting valuation rather than rejecting the story; hold and wait for AI pipeline conversions to show up in bookings.

ADYEY — REPORTED (EPS $0.41) | Stock: -3.5% Adyen raised growth guidance yet still fell 3.5% — the most counterintuitive reaction in the scorecard; this is likely a “sell the rip” after a pre-earnings run, or European ADR discount dynamics at play; analyst target of $17.48 vs. current price suggests the selloff is overdone — worth monitoring for a re-entry.

CASY — REPORTED (EPS $20.77) | Stock: -1.5% Casey’s General Stores maintained outlook on food and fuel strength with a massive absolute EPS figure, yet slipped 1.5% — with analyst target at $936.76 this is likely noise; no action needed, the business is fine.

INNV — REPORTED (EPS -$0.02) | Stock: +4.7% InnovAge reported strong EBITDA growth with near-breakeven EPS, and the market rewarded it with a 4.7% pop — analyst target at $10.50 implies the move may have legs; justified reaction, worth watching.

This brief is for informational purposes only and does not constitute investment advice. All technical levels are derived from the provided data. Past performance does not guarantee future results.